Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Visolis logo — Building decentralized supply chains for critical chemicals...

Visolis

Building decentralized supply chains for critical chemicals and fuels through biomanufacturing.

Founded 2012 United States Hayward, United States 16 employees Total: $14.41M Biotechnology, ESG +3

General Information

Company Name Visolis
Founded Year 2012
Location United States Hayward, United States
Employees 16
Industries Biotechnology, ESG, Health Care +2
Social

BounceWatch is an independent company data service, not affiliated with Visolis. To contact Visolis, visit visolisbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Visolis compare?

A PDF of Visolis and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Visolis soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Visolis

Visolis is a biotechnology startup that focuses on commercializing renewable technologies for consumers and the chemical industry. The company utilizes synthetic biology to manufacture high-performance materials with a unique bio-based process that enables true carbon-negative chemical synthesis. Located in Hayward, CA and Geleen, Netherlands, Visolis has established close collaborations with Lawrence Berkeley National Lab, Pacific Northwest National Lab, and University of California, Berkeley. Since its foundation in 2012, the company has secured funding from prominent institutions such as the Bill and Melinda Gates Foundation, US Department of Energy, the National Science Foundation, and the U.S. Department of Agriculture. Having a strong presence in Biotechnology, ESG, Health Care, Renewable Energy, and Sustainability sectors, Visolis recently received a $1.65M grant investment from the US Department of Energy on 22 February 2023. This funding is indicative of the confidence and support that the company has garnered from the government entities, further reinforcing its potential for growth and impact in the biotechnology and sustainable energy landscape.

Business keywords: Renewable Technologies, Synthetic Biology, Chemical Industry, Bio-based Manufacturing, Carbon-negative Synthesis, Chemical Catalysis, Process Scale-up, Bioengineering, Sustainable Chemicals, Fermentation, Process Engineering, High Performance Polymers, Research Collaboration, Funding from Government Agencies

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $2.86M 1
US Department of War
01 Jan 2026
Grant $2.25M 1
First Bight Ventures
First Bight Ventures
01 Oct 2024
Early VC $8.00M 7
Blue Yard Capital Creative Ventures Incite
Blue Yard Capital, Creative Ventures +5
01 Jan 2023
Early VC Undisclosed -
01 Oct 2017
Grant $1.20M 1
National Science Foundation
National Science Foundation
01 Mar 2017
Grant €50.00K 1
European Commission
01 Apr 2015
Grant €50.00K 1
European Innovation Council
European Innovation Council
01 Dec 2014
Spinout Undisclosed 1
Massachusetts Institute of Technology
01 Jan 2012

Visolis Alternatives & Competitors

View All Alternatives
Visolis vs
Viridos
Viridos United States

See how algae moves us.

Series A
53 employees
Biotechnology, Health Care
Visolis vs
Evolva
Evolva Switzerland

At Evolva we believe in applying technology platforms, such as fermentation, to help resolve sourcin...

Grant
74 employees
Biotechnology, Food and Beverage
Visolis vs
Camena Bioscience
Camena Bioscience United Kingdom

Unlocking access to genes with unparalleled accuracy

Series A
23 employees
Biotechnology, Health Care
View all alternatives

FAQ About Visolis

Building decentralized supply chains for critical chemicals and fuels through biomanufacturing.
Visolis was founded in 2012.
Visolis is headquartered in Hayward, United States.
Visolis operates in Biotechnology, ESG, Health Care, Renewable Energy and Sustainability. Its work centres on Renewable Technologies, Synthetic Biology, Chemical Industry and Bio-based Manufacturing.
Visolis has approximately 16 employees.
Visolis has completed 8 funding rounds, raising a total of $14.41M.
Top alternatives and competitors to Visolis include Viridos, Evolva, Camena Bioscience, Anthrogen, String Bio Private Limited. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Visolis and Viridos are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Visolis, https://bouncewatch.com/company/visolis, updated 25 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout